Zhengye Biotechnology Holding Limited
ZYBT
$6.70
-$2.79-29.40%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.91M | 26.12M | 26.28M | 28.06M | 29.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.91M | 26.12M | 26.28M | 28.06M | 29.99M |
| Cost of Revenue | 13.22M | 12.63M | 12.01M | 12.64M | 13.32M |
| Gross Profit | 12.69M | 13.49M | 14.27M | 15.42M | 16.67M |
| SG&A Expenses | 8.63M | 8.56M | 8.48M | 8.52M | 8.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.63M | 22.86M | 22.04M | 22.76M | 23.59M |
| Operating Income | 2.28M | 3.26M | 4.23M | 5.30M | 6.40M |
| Income Before Tax | 2.00M | 3.06M | 4.12M | 5.15M | 6.22M |
| Income Tax Expenses | 127.10K | 448.30K | 769.40K | 825.10K | 884.80K |
| Earnings from Continuing Operations | 1.87 | 2.61 | 3.35 | 4.32 | 5.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -299.70K | -418.60K | -536.80K | -696.00K | -860.80K |
| Net Income | 1.57M | 2.19M | 2.81M | 3.63M | 4.47M |
| EBIT | 2.28M | 3.26M | 4.23M | 5.30M | 6.40M |
| EBITDA | 5.64M | 6.56M | 7.46M | 8.59M | 9.78M |
| EPS Basic | 0.03 | 0.05 | 0.06 | 0.08 | 0.10 |
| Normalized Basic EPS | 0.02 | 0.03 | 0.04 | 0.06 | 0.07 |
| EPS Diluted | 0.03 | 0.05 | 0.06 | 0.08 | 0.10 |
| Normalized Diluted EPS | 0.02 | 0.03 | 0.04 | 0.06 | 0.07 |
| Average Basic Shares Outstanding | 182.67M | 182.67M | 182.67M | 182.67M | 182.67M |
| Average Diluted Shares Outstanding | 182.67M | 182.67M | 182.67M | 182.67M | 182.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 141.52% | 168.68% | 183.89% | 147.65% | 124.41% |